PRKCB
Protein kinase C beta type
Also known as: KPCB_HUMAN, PKCB, PKCbeta, PRKCB1, PRKCB2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P05771
- Gene
- PRKCB
- Ensembl
- ENSG00000166501
- Chromosome
- 16
- Canonical length
- 671 aa
- Protein class
- Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase has been reported to be involved in many different cellular functions, such as B cell activation, apoptosis induction, endothelial cell proliferation, and intestinal sugar absorption. Studies in mice also suggest that this kinase may also regulate neuronal functions and correlate fear-induced conflict behavior after stress. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
671 residues, UniProt reviewed canonical sequence.
>P05771|PRKCB
1 MADPAAGPPP SEGEESTVRF ARKGALRQKN VHEVKNHKFT ARFFKQPTFC SHCTDFIWGF
61 GKQGFQCQVC CFVVHKRCHE FVTFSCPGAD KGPASDDPRS KHKFKIHTYS SPTFCDHCGS
121 LLYGLIHQGM KCDTCMMNVH KRCVMNVPSL CGTDHTERRG RIYIQAHIDR DVLIVLVRDA
181 KNLVPMDPNG LSDPYVKLKL IPDPKSESKQ KTKTIKCSLN PEWNETFRFQ LKESDKDRRL
241 SVEIWDWDLT SRNDFMGSLS FGISELQKAS VDGWFKLLSQ EEGEYFNVPV PPEGSEANEE
301 LRQKFERAKI SQGTKVPEEK TTNTVSKFDN NGNRDRMKLT DFNFLMVLGK GSFGKVMLSE
361 RKGTDELYAV KILKKDVVIQ DDDVECTMVE KRVLALPGKP PFLTQLHSCF QTMDRLYFVM
421 EYVNGGDLMY HIQQVGRFKE PHAVFYAAEI AIGLFFLQSK GIIYRDLKLD NVMLDSEGHI
481 KIADFGMCKE NIWDGVTTKT FCGTPDYIAP EIIAYQPYGK SVDWWAFGVL LYEMLAGQAP
541 FEGEDEDELF QSIMEHNVAY PKSMSKEAVA ICKGLMTKHP GKRLGCGPEG ERDIKEHAFF
601 RYIDWEKLER KEIQPPYKPK ARDKRDTSNF DKEFTRQPVE LTPTDKLFIM NLDQNEFAGF
661 SYTNPEFVIN VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKCB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 105 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 105 nTPM
- basal ganglia: 93 nTPM
- lymph node: 44 nTPM
- thymus: 44 nTPM
- spleen: 44 nTPM
- hippocampal formation: 42 nTPM
Single-cell type
- neutrophils: 4,257 nCPM
- b-cells: 1,418 nCPM
- neutrophil progenitors: 1,343 nCPM
- kupffer cells: 1,055 nCPM
- thymocytes: 890 nCPM
- monocytes: 812 nCPM
Immune cell
- memory B-cell: 44 nTPM
- naive B-cell: 40 nTPM
- NK-cell: 40 nTPM
- basophil: 40 nTPM
- neutrophil: 39 nTPM
- plasmacytoid DC: 34 nTPM
Brain region
- cerebral cortex: 248 nTPM
- basal ganglia: 186 nTPM
- white matter: 148 nTPM
- hippocampal formation: 100 nTPM
- spinal cord: 46 nTPM
- pons: 41 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRKCB.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 81 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.08
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.99
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- apoptotic process
- B cell activation
- B cell receptor signaling pathway
- calcium ion transport
- cellular response to carbohydrate stimulus
- intracellular calcium ion homeostasis
- intracellular signal transduction
- lipoprotein transport
- mitotic nuclear membrane disassembly
- negative regulation of D-glucose transmembrane transport
- negative regulation of insulin receptor signaling pathway
- phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway
- positive regulation of angiogenesis
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of ferroptosis
- positive regulation of insulin secretion
- positive regulation of vascular endothelial growth factor receptor signaling pathway
- presynaptic modulation of chemical synaptic transmission
- protein kinase C signaling
- protein phosphorylation
- regulation of D-glucose transmembrane transport
- regulation of synaptic vesicle exocytosis
- regulation of transcription by RNA polymerase II
- signal transduction
Molecular functions
- ATP binding
- calcium channel regulator activity
- calcium,diacylglycerol-dependent serine/threonine kinase activity
- chromatin binding
- diacylglycerol-dependent serine/threonine kinase activity
- histone binding
- histone H3T6 kinase activity
- nuclear androgen receptor binding
- protein kinase C binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- transcription coactivator activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Protein kinase domain
- AGC-kinase, C-terminal
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase C, alpha/beta/gamma types
- Protein kinase, ATP binding site
- Protein kinase, C-terminal
- Diacylglycerol/phorbol-ester binding
- C2 domain superfamily
- C1-like domain superfamily
- Protein kinase domain
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- C2 domain
- Protein kinase C terminal domain
- Classical protein kinase C beta, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKCB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKCB as an antibody target. Whether an autoantibody or antibody against PRKCB could matter depends on whether native PRKCB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKCB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRKCB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...